Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal (MenB) Disease Recommendations in Older Adolescents and Young Adults.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,326
- 试验地点
- 6
- 主要终点
- Knowledge about MenB vaccine efficacy, potential benefits, possible side effects
研究概览
简要总结
As part of an effort to increase MenB vaccine uptake among adolescents and young adults, study teams will conduct qualitative research to maximize the effectiveness of nationally recommended MenB educational materials. In this study, Study Teams will assess local barriers to MenB vaccination by conducting focus groups with parents, students, and health care professionals.
详细描述
Participants (parents of 16-23 year old teens and young adults, high school and college students 16-23 years old, and health care professionals for 16-23 year olds) will be asked to share their thoughts on the completeness of nationally recommended and publicly available MenB vaccine educational materials in addressing hesitations to receipt of the MenB vaccine. There is no risk in discussing reactions to educational materials. The biggest risk is disclosure of information provided in the study which will be reactions to health-promotion material.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 16 Years 至 99 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Must be able to provide informed consent or assent
排除标准
- •Inability to provide informed consent or assent
研究组 & 干预措施
Youth
Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components.
干预措施: Awareness (Other)
Youth
Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components.
干预措施: Education (Other)
Youth
Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components.
干预措施: Empowerment (Other)
Youth
Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components.
干预措施: Accessibility (Other)
College
Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components.
干预措施: Awareness (Other)
College
Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components.
干预措施: Education (Other)
College
Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components.
干预措施: Empowerment (Other)
College
Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components.
干预措施: Accessibility (Other)
Adult
parents of adolescents and young adults will be offered awareness, education, and accessibility intervention components.
干预措施: Awareness (Other)
Adult
parents of adolescents and young adults will be offered awareness, education, and accessibility intervention components.
干预措施: Education (Other)
Adult
parents of adolescents and young adults will be offered awareness, education, and accessibility intervention components.
干预措施: Accessibility (Other)
Parent focus group
Parents discussed barriers and reviewed MenB education materials.
Provider focus groups
Providers discussed barriers and reviewed MenB education materials.
结局指标
主要结局
Knowledge about MenB vaccine efficacy, potential benefits, possible side effects
时间窗: 12 months
Percent of parents and young adults with Men B knowledge
Vaccine uptake in adolescents and young adults
时间窗: 12 months
Percentage receiving MenB vaccine
次要结局
- Attitudes re: Meningococcal B vaccine(12 months)